Reliability and performance that only INOMAX Total Care® can provide

INOMAX Total Care is backed by Mallinckrodt Pharmaceuticals’ commitment to critical care. We seek to assist critically ill patients and the clinicians who care for them through clinical and technological innovation.Our legacy of trusted performance includes:

  • Over 14 years of experience in critical care settings
  • More than 600,000 patients treated with INOMAX worldwide1
  • The only FDA-inspected nitric oxide drug manufacturing facilities in the United States
  • Ongoing investments in clinical research and device enhancement

For emergency services call 1-877-566-9466.